According to Research, the global market for Oral Blood Glucose Regulators should grow from US$ 61200 million in 2022 to US$ 131610 million by 2029, with a CAGR of 12.7% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Oral Blood Glucose Regulators market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Oral Blood Glucose Regulators market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Oral Blood Glucose Regulators are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report studies and analyses global Oral Blood Glucose Regulators status and future trends, helps the client to determine the Oral Blood Glucose Regulators market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Oral Blood Glucose Regulators, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Oral Blood Glucose Regulators market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Oral Blood Glucose Regulators sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Oral Blood Glucose Regulators sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Oral Blood Glucose Regulators key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Oral Blood Glucose Regulators key producing regions, capacity, production, and year over year growth
(6) Oral Blood Glucose Regulators industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bayer
Merck
Novartis
Huadong Medicine
Sanofi
Novo Nordisk
Servier
Takeda Pharmaceutical
Luye Pharmaceutical
Taiji Group
CR Double-Crane
AstraZeneca
Boehringer Ingelheim
Qilu Pharmaceutical
Jiangsu Deyuan Pharmaceutical
CTTQ
Market segment by Type, covers
Biguanides
Sulfonylureas
Meglitinides
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
SGLT2 Inhibitors
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Other
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Oral Blood Glucose Regulators product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Oral Blood Glucose Regulators market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Oral Blood Glucose Regulators market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Oral Blood Glucose Regulators, percent & CAGR, 2018-2029
Chapter 5: Oral Blood Glucose Regulators industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Oral Blood Glucose Regulators Definition
1.2 Global Oral Blood Glucose Regulators Market Size and Forecast
1.2.1 By Consumption Value, Global Oral Blood Glucose Regulators Market Size,2018-2029
1.2.2 By Sales Quantity, Global Oral Blood Glucose Regulators Market Size,2018-2029
1.2.3 Global Oral Blood Glucose Regulators Average Selling Price (ASP),2018-2029
1.3 China Oral Blood Glucose Regulators Market Size and Forecast
1.3.1 By Consumption Value, China Oral Blood Glucose Regulators Market Size,2018-2029
1.3.2 By Sales Quantity, China Oral Blood Glucose Regulators Market Size,2018-2029
1.3.3 China Oral Blood Glucose Regulators Average Selling Price (ASP), 2018-2029
1.4 Share of China Oral Blood Glucose Regulators Market with Respect to the Global Market
1.4.1 By Consumption Value, China Oral Blood Glucose Regulators Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Oral Blood Glucose Regulators Market Share in Global, 2018-2029
1.4.3 Oral Blood Glucose Regulators Market Size: China VS Global, 2018-2029
1.5 Oral Blood Glucose Regulators Market Dynamics
1.5.1 Oral Blood Glucose Regulators Market Drivers
1.5.2 Oral Blood Glucose Regulators Market Restraints
1.5.3 Oral Blood Glucose Regulators Industry Trends
1.5.4 Oral Blood Glucose Regulators Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Oral Blood Glucose Regulators, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Oral Blood Glucose Regulators, Global Market Share by Company, 2018-2023
2.3 Oral Blood Glucose Regulators Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Oral Blood Glucose Regulators Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Oral Blood Glucose Regulators Concentration Ratio
2.6 Global Oral Blood Glucose Regulators Mergers & Acquisitions, Expansion Plans
2.7 Global Oral Blood Glucose Regulators Manufacturers Product Type
2.8 Head Office and Oral Blood Glucose Regulators Production Site of Key Manufacturer
2.9 Oral Blood Glucose Regulators Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Oral Blood Glucose Regulators, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Oral Blood Glucose Regulators, China Market Share by Company, 2018-2023
3.3 China Oral Blood Glucose Regulators Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Oral Blood Glucose Regulators Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Oral Blood Glucose Regulators Capacity by Region
4.3 Global Oral Blood Glucose Regulators Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Oral Blood Glucose Regulators Production by Region, 2018-2029
4.5 Global Oral Blood Glucose Regulators Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Oral Blood Glucose Regulators Industry Chain
5.2 Oral Blood Glucose Regulators Upstream Analysis
5.2.1 Oral Blood Glucose Regulators Core Raw Materials
5.2.2 Main Manufacturers of Oral Blood Glucose Regulators Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Oral Blood Glucose Regulators Production Mode
5.6 Oral Blood Glucose Regulators Procurement Model
5.7 Oral Blood Glucose Regulators Industry Sales Model and Sales Channels
5.7.1 Oral Blood Glucose Regulators Sales Model
5.7.2 Oral Blood Glucose Regulators Typical Distributors
6 Sights by Type
6.1 Oral Blood Glucose Regulators Classification
6.1.1 Biguanides
6.1.2 Sulfonylureas
6.1.3 Meglitinides
6.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
6.1.5 SGLT2 Inhibitors
6.1.6 Thiazolidinediones
6.1.7 Alpha-Glucosidase Inhibitors
6.1.8 Other
6.2 By Type, Global Oral Blood Glucose Regulators Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029
6.4 By Type, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029
6.5 By Type, Global Oral Blood Glucose Regulators Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Oral Blood Glucose Regulators Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 By Application, Global Oral Blood Glucose Regulators Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029
7.4 By Application, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029
7.5 By Application, Global Oral Blood Glucose Regulators Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Oral Blood Glucose Regulators Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029
8.3 By Region, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Oral Blood Glucose Regulators & Forecasts, 2018-2029
8.4.2 By Country, North America Oral Blood Glucose Regulators Market Size Market Share
8.5 Europe
8.5.1 Europe Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Oral Blood Glucose Regulators Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Oral Blood Glucose Regulators Market Size Market Share
8.7 South America
8.7.1 South America Oral Blood Glucose Regulators Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Oral Blood Glucose Regulators Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Oral Blood Glucose Regulators Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029
9.3 By Country, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Oral Blood Glucose Regulators Market Size, 2018-2029
9.4.2 By Type, U.S. Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Oral Blood Glucose Regulators Market Size, 2018-2029
9.5.2 By Type, Europe Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Oral Blood Glucose Regulators Market Size, 2018-2029
9.6.2 By Type, China Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Oral Blood Glucose Regulators Market Size, 2018-2029
9.7.2 By Type, Japan Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Oral Blood Glucose Regulators Market Size, 2018-2029
9.8.2 By Type, South Korea Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Oral Blood Glucose Regulators Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Oral Blood Glucose Regulators Market Size, 2018-2029
9.10.2 By Type, India Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Oral Blood Glucose Regulators Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bayer
10.1.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.1.2 Bayer Oral Blood Glucose Regulators Models, Specifications, and Application
10.1.3 Bayer Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bayer Company Profile and Main Business
10.1.5 Bayer Recent Developments
10.2 Merck
10.2.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.2.2 Merck Oral Blood Glucose Regulators Models, Specifications, and Application
10.2.3 Merck Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck Company Profile and Main Business
10.2.5 Merck Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.3.2 Novartis Oral Blood Glucose Regulators Models, Specifications, and Application
10.3.3 Novartis Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 Huadong Medicine
10.4.1 Huadong Medicine Company Information, Head Office, Market Area, and Industry Position
10.4.2 Huadong Medicine Oral Blood Glucose Regulators Models, Specifications, and Application
10.4.3 Huadong Medicine Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Huadong Medicine Company Profile and Main Business
10.4.5 Huadong Medicine Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.5.2 Sanofi Oral Blood Glucose Regulators Models, Specifications, and Application
10.5.3 Sanofi Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Novo Nordisk
10.6.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
10.6.2 Novo Nordisk Oral Blood Glucose Regulators Models, Specifications, and Application
10.6.3 Novo Nordisk Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Novo Nordisk Company Profile and Main Business
10.6.5 Novo Nordisk Recent Developments
10.7 Servier
10.7.1 Servier Company Information, Head Office, Market Area, and Industry Position
10.7.2 Servier Oral Blood Glucose Regulators Models, Specifications, and Application
10.7.3 Servier Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Servier Company Profile and Main Business
10.7.5 Servier Recent Developments
10.8 Takeda Pharmaceutical
10.8.1 Takeda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Takeda Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
10.8.3 Takeda Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Takeda Pharmaceutical Company Profile and Main Business
10.8.5 Takeda Pharmaceutical Recent Developments
10.9 Luye Pharmaceutical
10.9.1 Luye Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Luye Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
10.9.3 Luye Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Luye Pharmaceutical Company Profile and Main Business
10.9.5 Luye Pharmaceutical Recent Developments
10.10 Taiji Group
10.10.1 Taiji Group Company Information, Head Office, Market Area, and Industry Position
10.10.2 Taiji Group Oral Blood Glucose Regulators Models, Specifications, and Application
10.10.3 Taiji Group Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Taiji Group Company Profile and Main Business
10.10.5 Taiji Group Recent Developments
10.11 CR Double-Crane
10.11.1 CR Double-Crane Company Information, Head Office, Market Area, and Industry Position
10.11.2 CR Double-Crane Oral Blood Glucose Regulators Models, Specifications, and Application
10.11.3 CR Double-Crane Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 CR Double-Crane Company Profile and Main Business
10.11.5 CR Double-Crane Recent Developments
10.12 AstraZeneca
10.12.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.12.2 AstraZeneca Oral Blood Glucose Regulators Models, Specifications, and Application
10.12.3 AstraZeneca Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 AstraZeneca Company Profile and Main Business
10.12.5 AstraZeneca Recent Developments
10.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.13.2 Boehringer Ingelheim Oral Blood Glucose Regulators Models, Specifications, and Application
10.13.3 Boehringer Ingelheim Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Boehringer Ingelheim Company Profile and Main Business
10.13.5 Boehringer Ingelheim Recent Developments
10.14 Qilu Pharmaceutical
10.14.1 Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Qilu Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
10.14.3 Qilu Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Qilu Pharmaceutical Company Profile and Main Business
10.14.5 Qilu Pharmaceutical Recent Developments
10.15 Jiangsu Deyuan Pharmaceutical
10.15.1 Jiangsu Deyuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
10.15.3 Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Jiangsu Deyuan Pharmaceutical Company Profile and Main Business
10.15.5 Jiangsu Deyuan Pharmaceutical Recent Developments
10.16 CTTQ
10.16.1 CTTQ Company Information, Head Office, Market Area, and Industry Position
10.16.2 CTTQ Oral Blood Glucose Regulators Models, Specifications, and Application
10.16.3 CTTQ Oral Blood Glucose Regulators Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CTTQ Company Profile and Main Business
10.16.5 CTTQ Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Oral Blood Glucose Regulators Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oral Blood Glucose Regulators Market Restraints
Table 3. Oral Blood Glucose Regulators Market Trends
Table 4. Oral Blood Glucose Regulators Industry Policy
Table 5. Global Oral Blood Glucose Regulators Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Oral Blood Glucose Regulators Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Oral Blood Glucose Regulators Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Oral Blood Glucose Regulators Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Oral Blood Glucose Regulators Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Oral Blood Glucose Regulators Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Oral Blood Glucose Regulators Mergers & Acquisitions, Expansion Plans
Table 12. Global Oral Blood Glucose Regulators Manufacturers Product Type
Table 13. Head Office and Oral Blood Glucose Regulators Production Site of Key Manufacturer
Table 14. Oral Blood Glucose Regulators Capacity of Major Manufacturers and Future Plan
Table 15. China Oral Blood Glucose Regulators Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Oral Blood Glucose Regulators Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Oral Blood Glucose Regulators Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Oral Blood Glucose Regulators Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Oral Blood Glucose Regulators Production by Region, 2018-2023, (K Units)
Table 20. Global Oral Blood Glucose Regulators Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Oral Blood Glucose Regulators Upstream (Raw Materials)
Table 22. Global Oral Blood Glucose Regulators Typical Customers
Table 23. Oral Blood Glucose Regulators Typical Distributors
Table 24. By Type, Global Oral Blood Glucose Regulators Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Oral Blood Glucose Regulators Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Oral Blood Glucose Regulators Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Oral Blood Glucose Regulators Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Oral Blood Glucose Regulators Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Oral Blood Glucose Regulators Sales Quantity Market Share, 2018-2029
Table 34. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 35. Bayer Oral Blood Glucose Regulators Models, Specifications, and Application
Table 36. Bayer Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bayer Company Profile and Main Business
Table 38. Bayer Recent Developments
Table 39. Merck Company Information, Head Office, Market Area, and Industry Position
Table 40. Merck Oral Blood Glucose Regulators Models, Specifications, and Application
Table 41. Merck Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 45. Novartis Oral Blood Glucose Regulators Models, Specifications, and Application
Table 46. Novartis Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. Huadong Medicine Company Information, Head Office, Market Area, and Industry Position
Table 50. Huadong Medicine Oral Blood Glucose Regulators Models, Specifications, and Application
Table 51. Huadong Medicine Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Huadong Medicine Company Profile and Main Business
Table 53. Huadong Medicine Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi Oral Blood Glucose Regulators Models, Specifications, and Application
Table 56. Sanofi Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
Table 60. Novo Nordisk Oral Blood Glucose Regulators Models, Specifications, and Application
Table 61. Novo Nordisk Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Novo Nordisk Company Profile and Main Business
Table 63. Novo Nordisk Recent Developments
Table 64. Servier Company Information, Head Office, Market Area, and Industry Position
Table 65. Servier Oral Blood Glucose Regulators Models, Specifications, and Application
Table 66. Servier Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Servier Company Profile and Main Business
Table 68. Servier Recent Developments
Table 69. Takeda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Takeda Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
Table 71. Takeda Pharmaceutical Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Takeda Pharmaceutical Company Profile and Main Business
Table 73. Takeda Pharmaceutical Recent Developments
Table 74. Luye Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Luye Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
Table 76. Luye Pharmaceutical Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Luye Pharmaceutical Company Profile and Main Business
Table 78. Luye Pharmaceutical Recent Developments
Table 79. Taiji Group Company Information, Head Office, Market Area, and Industry Position
Table 80. Taiji Group Oral Blood Glucose Regulators Models, Specifications, and Application
Table 81. Taiji Group Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Taiji Group Company Profile and Main Business
Table 83. Taiji Group Recent Developments
Table 84. CR Double-Crane Company Information, Head Office, Market Area, and Industry Position
Table 85. CR Double-Crane Oral Blood Glucose Regulators Models, Specifications, and Application
Table 86. CR Double-Crane Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. CR Double-Crane Company Profile and Main Business
Table 88. CR Double-Crane Recent Developments
Table 89. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 90. AstraZeneca Oral Blood Glucose Regulators Models, Specifications, and Application
Table 91. AstraZeneca Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. AstraZeneca Company Profile and Main Business
Table 93. AstraZeneca Recent Developments
Table 94. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 95. Boehringer Ingelheim Oral Blood Glucose Regulators Models, Specifications, and Application
Table 96. Boehringer Ingelheim Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Boehringer Ingelheim Company Profile and Main Business
Table 98. Boehringer Ingelheim Recent Developments
Table 99. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 100. Qilu Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
Table 101. Qilu Pharmaceutical Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Qilu Pharmaceutical Company Profile and Main Business
Table 103. Qilu Pharmaceutical Recent Developments
Table 104. Jiangsu Deyuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Models, Specifications, and Application
Table 106. Jiangsu Deyuan Pharmaceutical Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jiangsu Deyuan Pharmaceutical Company Profile and Main Business
Table 108. Jiangsu Deyuan Pharmaceutical Recent Developments
Table 109. CTTQ Company Information, Head Office, Market Area, and Industry Position
Table 110. CTTQ Oral Blood Glucose Regulators Models, Specifications, and Application
Table 111. CTTQ Oral Blood Glucose Regulators Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. CTTQ Company Profile and Main Business
Table 113. CTTQ Recent Developments
List of Figures
Figure 1. Oral Blood Glucose Regulators Picture
Figure 2. Global Oral Blood Glucose Regulators Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Oral Blood Glucose Regulators Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Oral Blood Glucose Regulators Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Oral Blood Glucose Regulators Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Oral Blood Glucose Regulators Sales Quantity (K Units) & (2018-2029)
Figure 7. China Oral Blood Glucose Regulators Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Oral Blood Glucose Regulators Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Oral Blood Glucose Regulators Market Share of Global, 2018-2029
Figure 10. Global Oral Blood Glucose Regulators Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Oral Blood Glucose Regulators Key Participants, Market Share, 2022
Figure 12. Global Oral Blood Glucose Regulators Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Oral Blood Glucose Regulators Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Oral Blood Glucose Regulators Production Market Share & Forecast by Region, 2018-2029
Figure 15. Oral Blood Glucose Regulators Industry Chain
Figure 16. Oral Blood Glucose Regulators Procurement Model
Figure 17. Oral Blood Glucose Regulators Sales Model
Figure 18. Oral Blood Glucose Regulators Sales Channels, Direct Sales, and Distribution
Figure 19. Biguanides
Figure 20. Sulfonylureas
Figure 21. Meglitinides
Figure 22. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 23. SGLT2 Inhibitors
Figure 24. Thiazolidinediones
Figure 25. Alpha-Glucosidase Inhibitors
Figure 26. Other
Figure 27. By Type, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029, US$ Million
Figure 28. By Type, Global Oral Blood Glucose Regulators Consumption Value Market Share, 2018-2029
Figure 29. By Type, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 30. By Type, Global Oral Blood Glucose Regulators Sales Quantity Market Share, 2018-2029
Figure 31. By Type, Global Oral Blood Glucose Regulators Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 32. Hospital
Figure 33. Clinic
Figure 34. Other
Figure 35. By Application, Global Oral Blood Glucose Regulators Consumption Value, 2018-2029, US$ Million
Figure 36. By Application, Global Oral Blood Glucose Regulators Consumption Value Market Share, 2018-2029
Figure 37. By Application, Global Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 38. By Application, Global Oral Blood Glucose Regulators Sales Quantity Market Share, 2018-2029
Figure 39. By Application, Global Oral Blood Glucose Regulators Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 40. By Region, Global Oral Blood Glucose Regulators Consumption Value Market Share, 2018-2029
Figure 41. By Region, Global Oral Blood Glucose Regulators Sales Quantity Market Share, 2018-2029
Figure 42. North America Oral Blood Glucose Regulators Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Oral Blood Glucose Regulators Consumption Value Market Share, 2022
Figure 44. Europe Oral Blood Glucose Regulators Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Oral Blood Glucose Regulators Consumption Value Market Share, 2022
Figure 46. Asia Pacific Oral Blood Glucose Regulators Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Oral Blood Glucose Regulators Consumption Value Market Share, 2022
Figure 48. South America Oral Blood Glucose Regulators Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Oral Blood Glucose Regulators Consumption Value Market Share, 2022
Figure 50. Middle East & Africa Oral Blood Glucose Regulators Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, U.S. Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 54. Europe Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Europe Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Europe Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 57. China Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, China Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, China Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 60. Japan Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Japan Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Japan Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 63. South Korea Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, South Korea Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, South Korea Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 66. Southeast Asia Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Southeast Asia Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Southeast Asia Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 69. India Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, India Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, India Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 72. Middle East & Africa Oral Blood Glucose Regulators Sales Quantity, 2018-2029, (K Units)
Figure 73. By Type, Middle East & Africa Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 74. By Application, Middle East & Africa Oral Blood Glucose Regulators Sales Quantity Market Share, 2022 VS 2029
Figure 75. Research Methodology
Figure 76. Breakdown of Primary Interviews
Figure 77. Bottom-up and Top-down Approaches
Figure 78. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|